Can-Fite BioPharma Ltd. (CANF): Total Assets
$9.51M
As of 2025-12-31
+0.8%
3-year compound annual growth
0.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.51M | +4.3% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $9.12M | -8.7% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $9.99M | +7.6% | 2025-04-14, Balance as of period end |
| 2022-12-31 | $9.28M | -54.2% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $20.25M | +112.7% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $9.52M | +16.5% | 2022-03-24, Balance as of period end |
| 2019-12-31 | $8.17M | n/a | 2021-03-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $9.51M | +4.3% |
| Medicinova Inc (MNOV) | 2025-12-31 | $45.60M | -18.4% |
| America Great Health (AAGH) | 2025-06-30 | $301.8K | -6.7% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $84.18M | -19.7% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $697.5K | -30.7% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $45.92M | -39.9% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $18.26M | -19.4% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $6.50M | +370.3% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.67M | -25.3% |
Compare CANF, MNOV, AAGH, SCNX side by side · Screen every company in Pharmaceutical Preparations ↗